Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Mental Dysfunction in Parkinson's Disease
Article type: Review Article
Authors: Takeda, Atsushi | Baba, Toru | Kikuchi, Akio | Hasegawa, Takafumi | Sugeno, Naoto | Konno, Masatoshi | Miura, Emiko | Mori, Etsuro
Affiliations: Department of Neurology, National Hospital Organization, Sendai-Nishitgaga Hospital, Kagitori-honcho, Taihaku-ku, Sendai, Japan | Department of Behavioral Neurology and Cognitive Neuroscience, Seiryo-machi, Aoba-ku, Sendai, Japan | Department of Neurology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Japan
Note: [] Correspondence to: Atsushi Takeda, M.D., Ph.D., Department of Neurology, National Hospital Organization, Sendai-Nishitgaga Hospital, 2-11-11 Kagitori-honcho, Taihaku-ku, Sendai 982-8555, Japan. E-mail: [email protected]
Abstract: Dementia is one of the most debilitating symptoms of Parkinson's disease (PD), but the development of dementia is still difficult to predict at early stages of the disease. We recently found that hyposmia, one of the most typical non-motor features of PD, was a predictive feature of Parkinson's disease with dementia (PDD). In that work, multivariate logistic analysis identified severe hyposmia and visuoperceptual impairment as independent risk factors for subsequent dementia within 3 years. The patients with severe hyposmia had an 18.7-fold increase in their risk of dementia for each 1 SD (2.8) decrease in scores on the odor stick identification test for Japanese (OSIT-J). We also found an association between severe hyposmia and a specific pattern of cerebral metabolic decline, which was identical to findings observed in PDD. Furthermore, volumetric magnetic resonance imaging analyses demonstrated close relationships between olfactory dysfunction and atrophy of focal brain structures, including the amygdala and other limbic structures. Our findings suggest that brain regions related to olfactory function are closely associated with cognitive decline and that severe hyposmia is a prominent clinical feature that predicts the subsequent development of PDD. We have now started a randomized, double-blind study using donepezil for the PD group with severe hyposmia. We hope that this clinical trial will allow us to establish a therapeutic intervention that can improve the prognosis of advanced PD.
Keywords: Hyposmia, Parkinson's disease with dementia, OSIT-J, PET, MRI
DOI: 10.3233/JPD-130277
Journal: Journal of Parkinson's Disease, vol. 4, no. 2, pp. 181-187, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]